The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

More than 4,000 beagle puppies are born every year on a remote Wisconsin farm about 30 minutes west of Madison. Some of them ...

Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...

UMass Chan Medical School biomedical engineer and professor Rachael Sirianni leads a lab that researches new technologies to ...

(Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Investment bankers say large pharma and biotech deals are stalling as executives grapple with mercurial White House economic ...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Existing treatments for endometriosis have changed little in the past 30 years and are often ineffective or have undesired ...

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having ...

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.